Cortical N-acetyl aspartate is a predictor of long-term clinical disability in multiple sclerosis

Keyphrases

• Expanded Disability Status Scale 100%
• Multiple Sclerosis 100%
• N-acetylaspartate 100%
• Clinical Disability 100%
• Relapsing-remitting multiple Sclerosis 33%
• Newly Diagnosed 11%
• Prognostic Value 11%
• Disease Outcome 11%
• Clinical Examination 11%
• Long-term Disease 11%
• Serial MRI 11%
• Brain Parenchymal Fraction 11%
• MR Spectroscopic Imaging 11%

Neuroscience

• Multiple Sclerosis 100%
• Expanded Disability Status Scale 100%
• N-Acetylaspartic Acid 100%
• Creatine 66%
• Relapsing Remitting Multiple Sclerosis 33%
• Magnetic Resonance Imaging 11%

Immunology and Microbiology

• Multiple Sclerosis 100%
• Expanded Disability Status Scale 100%
• Acetic Acid Derivative 100%
• Relapsing Remitting Multiple Sclerosis 33%
• Magnetic Resonance Imaging 11%
• Spectroscopic Imaging 11%